Literature DB >> 7746802

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.

B B Fredholm1.   

Abstract

Of the known biochemical actions of caffeine, only inhibition of adenosine receptors occurs at concentrations achieved during normal human consumption of the drug. Under normal physiological conditions, adenosine is present in sufficient concentrations to activate A1 and A2a receptors. Via actions on A1 receptors, adenosine decreases neuronal firing and the release of neurotransmitters. The exact mechanisms are not known, but several possibilities are discussed. Via actions on A2a receptors, adenosine--and hence caffeine--can influence dopaminergic neurotransmission. Caffeine can induce rapid changes in gene expression and, somewhat later, marked adaptive changes. These include antiepileptic and neuroprotective changes. Thus, caffeine has a number of central effects directly or indirectly related to adenosine receptors. Some of these are potentially useful, and drug development based on the actions of caffeine should be interesting.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746802     DOI: 10.1111/j.1600-0773.1995.tb00111.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  98 in total

1.  Effect of coffee on motor and sensory function of proximal stomach.

Authors:  P J Boekema; M Samsom; J M Roelofs; A J Smout
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors.

Authors:  N R Zahniser; J K Simosky; R D Mayfield; C A Negri; T Hanania; G A Larson; M A Kelly; D K Grandy; M Rubinstein; M J Low; B B Fredholm
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  "No thanks, coffee keeps me awake": individual caffeine sensitivity depends on ADORA2A genotype.

Authors:  Hans-Peter Landolt
Journal:  Sleep       Date:  2012-07-01       Impact factor: 5.849

Review 4.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

5.  Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.

Authors:  Bogachan Sahin; Stacey Galdi; Joseph Hendrick; Robert W Greene; Gretchen L Snyder; James A Bibb
Journal:  Brain Res       Date:  2006-12-06       Impact factor: 3.252

6.  Maternal hypoxia and caffeine exposure depress fetal cardiovascular function during primary organogenesis.

Authors:  Nobuo Momoi; Joseph P Tinney; Bradley B Keller; Kimimasa Tobita
Journal:  J Obstet Gynaecol Res       Date:  2012-05-21       Impact factor: 1.730

7.  Caffeine enhances activity thermogenesis and energy expenditure in rats.

Authors:  Kathryn S Clark; Claire Coleman; Rhiannon Shelton; Lydia A Heemstra; Colleen M Novak
Journal:  Clin Exp Pharmacol Physiol       Date:  2019-02-14       Impact factor: 2.557

Review 8.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

9.  The effect of caffeine on the ventilatory response to hypercarbia in preterm infants.

Authors:  Thomas Rossor; Ravindra Bhat; Kamal Ali; Janet Peacock; Gerrard F Rafferty; Anne Greenough
Journal:  Pediatr Res       Date:  2018-05-23       Impact factor: 3.756

Review 10.  Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates.

Authors:  Kok Pim Kua; Shaun Wen Huey Lee
Journal:  Br J Clin Pharmacol       Date:  2016-09-30       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.